The week in health tech, explained in plain English.Get the free newsletter →
October 25, 2026

Takeaways from the most recent news in the technology and policies shaping healthcare.

Payers

Elevance Sues Ex-Executive Over Move to Alignment Healthcare

Elevance Health is suing former senior executive Shane Hochradel, alleging he violated a noncompete agreement when he joined Medicare Advantage insurer Alignment Healthcare just weeks after resigning, according to Becker's Payer Issues. The complaint, filed June 5 in an Indiana federal court, points to Hochradel, who held a range of executive roles at Elevance starting in 2021.

The dispute reflects a broader tension across the insurance industry, where payers guard competitive strategy and senior talent closely. Medicare Advantage is one of the most contested and lucrative segments, making the movement of executives who know a rival's playbook especially sensitive. Lawsuits like this signal how aggressively large insurers will act to enforce restrictive employment terms.

The timing matters because noncompete agreements face growing legal and regulatory scrutiny nationally, with courts and agencies weighing how far employers can go to limit where workers take their next jobs. The outcome could offer a marker for how enforceable these clauses remain for high-level healthcare executives.

More in Payers

Payers

CMS Releases 2027 Medicare Advantage Star Ratings

CMS released its 2027 Medicare Advantage star ratings on Oct. 8, shaping quality bonus payments and how insurers compete for members.

Why it matters: Star ratings control billions in quality bonus payments that determine how generous Medicare Advantage plans can be.

Payers

Walmart to Make Some GLP-1s Free for Diabetic Workers in 2027

Walmart will make more than 250 medications, including some GLP-1s for Type 2 diabetes, free to employees starting in 2027.

Why it matters: How a major self-insured employer like Walmart structures GLP-1 coverage signals where corporate drug benefits are heading amid soaring demand.

Payers

Patients Are Taking Insurance Denials Straight to the C-Suite

Some patients are overturning insurance denials by emailing insurer CEOs directly, a workaround that exposes deeper flaws in the standard appeals process.

Why it matters: When patients must reach the CEO to get covered care approved, it signals the normal denial and appeals system is failing the people it should serve.